BC
Bradley Canino Guggenheim Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
21
Avg Return
Past Year
Past Year
11%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
93.3%
Neutral
6.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Initiated
| $90 |
117%
upside
| 1 | +9.1% |
0
%
| 8 Oct ‘25 11 days ago |
|
|
|
Buy
Initiated
| $20 |
114%
upside
| 1 | -10% |
0
%
| 8 Oct ‘25 11 days ago |
|
|
|
Buy
Initiated
| $110 |
112%
upside
| 1 | +0.15% |
0
%
| 22 Sep ‘25 27 days ago |
|
|
|
Buy
Reinstated
| $44 |
208%
upside
| 2 | -5.7% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
|
Buy
Reinstated
| $45 |
68%
upside
| 2 | -9% |
0
%
| 10 Sep ‘25 1 month ago |
|
|
|
Buy
Assumed
| $18 |
41%
upside
| 1 | +21% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Assumed
| $15 |
131%
upside
| 1 | +34% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Assumed
| $122 |
32%
upside
| 1 | +16% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $8 |
238%
upside
| 1 | -7.4% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Neutral
Initiated
| – | – | 1 | – |
–
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $8 |
100%
upside
| 1 | +45% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $40 |
91%
upside
| 1 | -11% |
0
%
| 4 Sep ‘25 1 month ago |
|
|
|
Buy
Initiated
| $5 |
49%
upside
| 1 | +129% |
0
%
| 4 Sep ‘25 1 month ago |
|